Passenger mutation

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

General informationThis section has been translated automatically.

The DNA of tumor cells is characterized by a combination of mutations: translocations, base pair exchanges and different sets of chromosomes. Of crucial importance is the question which mutations are of growth-determining importance for carcinogenesis.

The majority of detectable changes in the DNA code are so-called "passenger mutations". They arise in the course of the many cell divisions of a clone, but are not crucial for the survival and uninhibited proliferation of the cells. Crucial for this are the so-called "driver mutations" also known as drivers. These aberrations of the DNA give the tumour clone the decisive growth advantage over normal cells. So far, > 500 mutated key genes (oncogenes) have been discovered for individual tumours, which is about 2.5% of all protein-coding genes.

Authors

Last updated on: 29.10.2020